Health Cost Of Revenue vs Depreciation And Amortization Analysis

HCAT Stock

USD 8.50 0.02 0.23%

Health Catalyst financial indicator trend analysis is much more than just examining Health Catalyst latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Health Catalyst is a good investment. Please check the relationship between Health Catalyst Cost Of Revenue and its Depreciation And Amortization accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Health Catalyst. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Health Stock please use our How to Invest in Health Catalyst guide.

Cost Of Revenue vs Depreciation And Amortization

Cost Of Revenue vs Depreciation And Amortization Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Health Catalyst Cost Of Revenue account and Depreciation And Amortization. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Health Catalyst's Cost Of Revenue and Depreciation And Amortization is 0.97. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Depreciation And Amortization in the same time period over historical financial statements of Health Catalyst, assuming nothing else is changed. The correlation between historical values of Health Catalyst's Cost Of Revenue and Depreciation And Amortization is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Health Catalyst are associated (or correlated) with its Depreciation And Amortization. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Depreciation And Amortization has no effect on the direction of Cost Of Revenue i.e., Health Catalyst's Cost Of Revenue and Depreciation And Amortization go up and down completely randomly.

Correlation Coefficient

0.97

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Cost Of Revenue

Cost of Revenue is found on Health Catalyst income statement and represents the costs associated with goods and services Health Catalyst provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Depreciation And Amortization

The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.

Most indicators from Health Catalyst's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Health Catalyst current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Health Catalyst. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Health Stock please use our How to Invest in Health Catalyst guide.At this time, Health Catalyst's Tax Provision is comparatively stable compared to the past year. Enterprise Value is likely to gain to about 1.2 B in 2024, whereas Selling General Administrative is likely to drop slightly above 55.4 M in 2024.

	2021	2022	2023	2024 (projected)
Interest Expense	16.5M	1.7M	7.3M	7.0M
Depreciation And Amortization	41.1M	51.5M	45.2M	28.8M

Interest Expense Depreciation And Amortization

Health Catalyst fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Long Term Debt Total	Non Current Liabilities Total	Capital Lease Obligations
Total Assets		0.98	0.56	0.98	0.97	0.02	0.92	0.98	0.98	0.78	-0.92	0.92	0.94	0.98	0.97	0.38	0.98	0.98	0.95	0.97	0.96	0.89	0.94	0.9	-0.61	0.95
Short Long Term Debt Total	0.98		0.55	0.98	0.93	-0.02	0.87	0.99	0.97	0.86	-0.93	0.94	0.89	0.99	0.98	0.42	1.0	0.93	0.98	0.98	0.95	0.93	0.9	0.89	-0.54	0.96
Other Current Liab	0.56	0.55		0.61	0.5	0.57	0.43	0.62	0.48	0.38	-0.4	0.5	0.62	0.61	0.59	0.75	0.54	0.5	0.53	0.54	0.45	0.52	0.4	0.37	-0.23	0.7
Total Current Liabilities	0.98	0.98	0.61		0.94	0.12	0.89	0.99	0.99	0.82	-0.92	0.96	0.91	0.97	0.99	0.5	0.97	0.95	0.98	0.95	0.95	0.87	0.91	0.91	-0.58	0.98
Total Stockholder Equity	0.97	0.93	0.5	0.94		-0.06	0.99	0.91	0.95	0.81	-0.94	0.92	0.87	0.91	0.91	0.35	0.93	0.98	0.91	0.9	0.96	0.78	0.98	0.91	-0.78	0.89
Other Liab	0.02	-0.02	0.57	0.12	-0.06		-0.1	0.1	0.02	-0.31	0.23	0.0	0.18	0.03	0.07	0.72	-0.05	0.02	0.01	-0.07	-0.05	-0.14	-0.07	0.03	0.12	0.22
Net Tangible Assets	0.92	0.87	0.43	0.89	0.99	-0.1		0.84	0.9	0.78	-0.91	0.91	0.79	0.83	0.85	0.31	0.87	0.96	0.86	0.83	0.94	0.69	0.99	0.91	-0.86	0.81
Property Plant And Equipment Net	0.98	0.99	0.62	0.99	0.91	0.1	0.84		0.97	0.8	-0.9	0.91	0.94	0.99	0.99	0.46	0.98	0.94	0.96	0.98	0.92	0.92	0.87	0.86	-0.48	0.98
Current Deferred Revenue	0.98	0.97	0.48	0.99	0.95	0.02	0.9	0.97		0.83	-0.94	0.96	0.89	0.95	0.98	0.4	0.97	0.96	0.98	0.94	0.96	0.86	0.93	0.94	-0.6	0.95
Net Debt	0.78	0.86	0.38	0.82	0.81	-0.31	0.78	0.8	0.83		-0.92	0.86	0.59	0.79	0.8	0.33	0.86	0.73	0.86	0.8	0.8	0.79	0.77	0.75	-0.55	0.79
Retained Earnings	-0.92	-0.93	-0.4	-0.92	-0.94	0.23	-0.91	-0.9	-0.94	-0.92		-0.93	-0.8	-0.89	-0.92	-0.23	-0.93	-0.9	-0.94	-0.9	-0.91	-0.85	-0.9	-0.85	0.64	-0.86
Accounts Payable	0.92	0.94	0.5	0.96	0.92	0.0	0.91	0.91	0.96	0.86	-0.93		0.79	0.89	0.95	0.45	0.94	0.91	0.98	0.89	0.97	0.8	0.91	0.96	-0.67	0.91
Cash	0.94	0.89	0.62	0.91	0.87	0.18	0.79	0.94	0.89	0.59	-0.8	0.79		0.94	0.92	0.33	0.88	0.92	0.86	0.92	0.84	0.86	0.82	0.75	-0.42	0.9
Non Current Assets Total	0.98	0.99	0.61	0.97	0.91	0.03	0.83	0.99	0.95	0.79	-0.89	0.89	0.94		0.98	0.4	0.98	0.93	0.95	0.99	0.92	0.95	0.87	0.84	-0.47	0.96
Non Currrent Assets Other	0.97	0.98	0.59	0.99	0.91	0.07	0.85	0.99	0.98	0.8	-0.92	0.95	0.92	0.98		0.42	0.98	0.93	0.99	0.97	0.94	0.92	0.87	0.88	-0.49	0.97
Other Assets	0.38	0.42	0.75	0.5	0.35	0.72	0.31	0.46	0.4	0.33	-0.23	0.45	0.33	0.4	0.42		0.4	0.35	0.42	0.31	0.37	0.23	0.34	0.44	-0.27	0.6
Long Term Debt	0.98	1.0	0.54	0.97	0.93	-0.05	0.87	0.98	0.97	0.86	-0.93	0.94	0.88	0.98	0.98	0.4		0.93	0.97	0.99	0.96	0.94	0.9	0.89	-0.54	0.95
Cash And Short Term Investments	0.98	0.93	0.5	0.95	0.98	0.02	0.96	0.94	0.96	0.73	-0.9	0.91	0.92	0.93	0.93	0.35	0.93		0.91	0.92	0.96	0.81	0.98	0.92	-0.71	0.9
Net Receivables	0.95	0.98	0.53	0.98	0.91	0.01	0.86	0.96	0.98	0.86	-0.94	0.98	0.86	0.95	0.99	0.42	0.97	0.91		0.95	0.95	0.89	0.88	0.91	-0.54	0.95
Good Will	0.97	0.98	0.54	0.95	0.9	-0.07	0.83	0.98	0.94	0.8	-0.9	0.89	0.92	0.99	0.97	0.31	0.99	0.92	0.95		0.92	0.97	0.86	0.83	-0.45	0.93
Common Stock Total Equity	0.96	0.95	0.45	0.95	0.96	-0.05	0.94	0.92	0.96	0.8	-0.91	0.97	0.84	0.92	0.94	0.37	0.96	0.96	0.95	0.92		0.82	0.97	0.97	-0.72	0.89
Common Stock Shares Outstanding	0.89	0.93	0.52	0.87	0.78	-0.14	0.69	0.92	0.86	0.79	-0.85	0.8	0.86	0.95	0.92	0.23	0.94	0.81	0.89	0.97	0.82		0.73	0.69	-0.26	0.87
Short Term Investments	0.94	0.9	0.4	0.91	0.98	-0.07	0.99	0.87	0.93	0.77	-0.9	0.91	0.82	0.87	0.87	0.34	0.9	0.98	0.88	0.86	0.97	0.73		0.95	-0.82	0.84
Long Term Debt Total	0.9	0.89	0.37	0.91	0.91	0.03	0.91	0.86	0.94	0.75	-0.85	0.96	0.75	0.84	0.88	0.44	0.89	0.92	0.91	0.83	0.97	0.69	0.95		-0.75	0.85
Non Current Liabilities Total	-0.61	-0.54	-0.23	-0.58	-0.78	0.12	-0.86	-0.48	-0.6	-0.55	0.64	-0.67	-0.42	-0.47	-0.49	-0.27	-0.54	-0.71	-0.54	-0.45	-0.72	-0.26	-0.82	-0.75		-0.48
Capital Lease Obligations	0.95	0.96	0.7	0.98	0.89	0.22	0.81	0.98	0.95	0.79	-0.86	0.91	0.9	0.96	0.97	0.6	0.95	0.9	0.95	0.93	0.89	0.87	0.84	0.85	-0.48

Click cells to compare fundamentals

Health Catalyst Account Relationship Matchups

Health Catalyst fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	302.4M	577.7M	832.1M	752.3M	701.8M	532.3M
Short Long Term Debt Total	52.7M	195.3M	204.6M	248.0M	249.1M	155.4M
Other Current Liab	11.1M	30.3M	24.9M	16.3M	19.9M	20.6M
Total Current Liabilities	48.2M	88.0M	93.1M	82.5M	89.0M	74.4M
Total Stockholder Equity	200.6M	276.1M	522.1M	425.0M	366.9M	385.3M
Other Liab	3.6M	20.9M	15.8M	226K	203.4K	193.2K
Net Tangible Assets	171.4M	69.4M	247.3M	146.8M	168.9M	177.3M
Property Plant And Equipment Net	8.1M	37.6M	44.4M	42.6M	39.6M	29.7M
Current Deferred Revenue	30.7M	47.1M	56.6M	55.0M	55.8M	44.1M
Net Debt	34.6M	103.3M	11.4M	131.7M	142.8M	149.9M
Retained Earnings	(610.5M)	(725.7M)	(878.9M)	(999.0M)	(1.1B)	(1.2B)
Accounts Payable	3.6M	5.3M	4.7M	4.4M	6.6M	4.3M
Cash	18.0M	92.0M	193.2M	116.3M	106.3M	90.7M
Non Current Assets Total	38.1M	247.9M	323.7M	324.5M	308.4M	208.3M
Non Currrent Assets Other	810K	3.6M	4.5M	3.7M	4.7M	2.9M
Other Assets	810K	28.3M	4.5M	3.7M	1.0	0.95
Long Term Debt	48.2M	169.0M	180.9M	226.5M	228.0M	138.5M
Cash And Short Term Investments	228.3M	270.9M	445.0M	363.5M	317.7M	268.7M
Net Receivables	27.6M	48.3M	48.8M	48.0M	60.3M	43.6M
Common Stock Shares Outstanding	18.7M	39.5M	47.5M	54.1M	56.4M	42.7M
Short Term Investments	210.2M	178.9M	251.8M	247.2M	211.5M	178.0M
Liabilities And Stockholders Equity	302.4M	577.7M	832.1M	752.3M	701.8M	532.3M
Non Current Liabilities Total	53.5M	213.6M	216.9M	244.8M	245.9M	200.9M
Capital Lease Obligations	4.5M	26.3M	23.7M	21.5M	21.0M	16.8M
Other Current Assets	8.4M	9.6M	27.0M	16.3M	15.4M	13.5M
Other Stockholder Equity	508.7M	1.0B	1.4B	(648K)	(745.2K)	(707.9K)
Total Liab	101.7M	301.6M	310.0M	327.3M	334.9M	255.0M
Net Invested Capital	248.8M	445.1M	703.0M	651.5M	595.0M	320.4M
Property Plant And Equipment Gross	8.1M	12.9M	44.4M	42.6M	67.0M	70.3M
Total Current Assets	264.2M	329.8M	508.4M	427.8M	393.4M	324.0M
Accumulated Other Comprehensive Income	72K	61K	(67K)	(648K)	33K	34.7K
Non Current Liabilities Other	326K	19.1M	14.8M	121K	74K	70.3K
Net Working Capital	216.0M	241.8M	415.3M	345.3M	304.4M	249.6M
Short Term Debt	2.8M	5.2M	6.9M	6.9M	6.7M	5.4M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Health Stock Analysis

When running Health Catalyst's price analysis, check to measure Health Catalyst's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health Catalyst is operating at the current time. Most of Health Catalyst's value examination focuses on studying past and present price action to predict the probability of Health Catalyst's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health Catalyst's price. Additionally, you may evaluate how the addition of Health Catalyst to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC